These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27650011)

  • 1. Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy-Results From a Longitudinal Study.
    Menning S; de Ruiter MB; Kieffer JM; Agelink van Rentergem J; Veltman DJ; Fruijtier A; Oldenburg HS; Boven E; van der Meij S; Lustig V; Bos ME; Boogerd W; Reneman L; Schagen SB
    J Pain Symptom Manage; 2016 Oct; 52(4):560-569.e1. PubMed ID: 27650011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
    Crit Rev Oncol Hematol; 2010 Nov; 76(2):133-41. PubMed ID: 20036141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
    Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
    Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue.
    Menning S; de Ruiter MB; Veltman DJ; Koppelmans V; Kirschbaum C; Boogerd W; Reneman L; Schagen SB
    Neuroimage Clin; 2015; 7():547-54. PubMed ID: 25844311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
    Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
    Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
    Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
    Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
    Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
    J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
    Park JH; Bae SH; Jung YS; Jung YM
    J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-stroke cognitive impairment - A cross-sectional comparison study between mild cognitive impairment of vascular and non-vascular etiology.
    Divya KP; Menon RN; Varma RP; Sylaja PN; Thomas B; Kesavadas C; Sunitha J; Lekha VS; Deepak S
    J Neurol Sci; 2017 Jan; 372():356-362. PubMed ID: 27836108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada.
    Mariani M; Collins MWG
    Support Care Cancer; 2018 Nov; 26(11):3801-3809. PubMed ID: 29774475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients.
    Hermelink K; Bühner M; Sckopke P; Neufeld F; Kaste J; Voigt V; Münzel K; Wuerstlein R; Ditsch N; Hellerhoff K; Rjosk-Dendorfer D; Braun M; von Koch FE; Härtl K; Hasmüller S; Bauerfeind I; Debus G; Herschbach P; Mahner S; Harbeck N
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress.
    Hermelink K; Voigt V; Kaste J; Neufeld F; Wuerstlein R; Bühner M; Münzel K; Rjosk-Dendorfer D; Grandl S; Braun M; von Koch FE; Härtl K; Hasmüller S; Bauerfeind I; Debus G; Herschbach P; Harbeck N
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25882713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of adjuvant treatment on cognitive function in women with early breast cancer.
    Hedayati E; Alinaghizadeh H; Schedin A; Nyman H; Albertsson M
    Eur J Oncol Nurs; 2012 Jul; 16(3):315-22. PubMed ID: 21908235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
    Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
    J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
    Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
    Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.
    Deprez S; Amant F; Smeets A; Peeters R; Leemans A; Van Hecke W; Verhoeven JS; Christiaens MR; Vandenberghe J; Vandenbulcke M; Sunaert S
    J Clin Oncol; 2012 Jan; 30(3):274-81. PubMed ID: 22184379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive, psychosocial, somatic and treatment factors predicting return to work after breast cancer treatment.
    Hedayati E; Johnsson A; Alinaghizadeh H; Schedin A; Nyman H; Albertsson M
    Scand J Caring Sci; 2013 Jun; 27(2):380-7. PubMed ID: 22862138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial.
    Gokal K; Munir F; Ahmed S; Kancherla K; Wallis D
    PLoS One; 2018; 13(11):e0206874. PubMed ID: 30485297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
    Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
    Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.